Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03435640
Title A Study of NKTR-262 in Combination With NKTR-214 and With NKTR-214 Plus Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nektar Therapeutics
Indications

melanoma

colorectal cancer

ovarian carcinoma

renal cell carcinoma

triple-receptor negative breast cancer

Merkel cell carcinoma

transitional cell carcinoma

sarcoma

Therapies

NKTR-214 + NKTR-262

Nivolumab + NKTR-214 + NKTR-262

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.